{"entity":{"id":"nct05469022","kind":"trial","name":"Neoadjuvant Lazertinib Therapy in EGFR-Mutation Positive Lung Adenocarcinoma Detected by BALF Liquid Biopsy","aka":[],"tldr":"A phase 2 trial in lung cancer, run by Konkuk University Medical Center, now recruiting.","summary":"Neoadjuvant Lazertinib Therapy in EGFR-Mutation Positive Lung Adenocarcinoma Detected by BALF Liquid Biopsy is a phase 2, interventional study registered as NCT05469022 by Konkuk University Medical Center, with a registry enrolment figure of 40 participants, started 2022-05-19 and due to reach its primary completion in 2024-05-19. Interventions recorded: Neoadjuvant lazertinib. Conditions listed: Non Small Cell Lung Cancer. Primary outcome: Objective response rate. Lung eligibility wording from the registry: \"Patients with suspected lung cancer on chest CT findings\". Sites: South Korea. No results are recorded here; the registry entry is the source.","status":"recruiting","asOf":"2026-09-25","links":[{"label":"ClinicalTrials.gov NCT05469022","url":"https://clinicaltrials.gov/study/NCT05469022"}],"tags":["ctgov-ingest","lung-deep-dive"],"related":[],"cancers":["egfr-mutant-nsclc","resectable-nsclc"],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":["yuhan"],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"nct":"NCT05469022","phase":"2","setting":"A Phase II, Single-Center, Single-Arm, Prospective Study of Neoadjuvant Lazertinib Therapy in Resectable EGFR-Mutation Positive Lung Adenocarcinoma Patients Detected by Broncho-alveolar Lavage Fluid(BALF) Liquid Biopsy","sponsor":"Konkuk University Medical Center","enrolled":40,"enrolledBasis":"registry","outcomes":[]},"route":"/trials/nct05469022/","neighbours":{"cancer":[{"id":"egfr-mutant-nsclc","kind":"cancer","name":"EGFR-mutated non-small-cell lung cancer","route":"/cancers/egfr-mutant-nsclc/"},{"id":"resectable-nsclc","kind":"cancer","name":"Resectable stage I to III non-small-cell lung cancer","route":"/cancers/resectable-nsclc/"}],"company":[{"id":"yuhan","kind":"company","name":"Yuhan Corporation","route":"/companies/yuhan/"}],"term":[{"id":"lung-trials-open-today","kind":"term","name":"Lung cancer trials open today (registry snapshot)","route":"/terms/lung-trials-open-today/"}]}}